[Antitumor activity of shi-quan-da-bu-tang and its effects on interferon-gamma and interleukin 2 production].

Y. Sakagami,Y. Mizoguchi,K. Miyajima,H. Kuboi,K. Kobayashi,K. Kioka,H. Takeda,T. Shin,S. Morisawa,S. Yamamoto

Abstract:

What problem does this paper attempt to address?

An updated report of the trends in cancer incidence and mortality in Japan

Kota Katanoda,Tomohiro Matsuda,Ayako Matsuda,Akiko Shibata,Yoshikazu Nishino,Manabu Fujita,Midori Soda,Akiko Ioka,Tomotaka Sobue,Hiroshi Nishimoto

DOI: https://doi.org/10.1093/jjco/hyt038

Abstract:Objective: The analysis of cancer trends in Japan has only been sporadically reported. We present a comprehensive report on the trends in cancer incidence and mortality in Japan using the most recent population-based data. Methods: National cancer mortality data between 1958 and 2011 were obtained from published vital statistics. Cancer incidence data between 1985 and 2007 were obtained from high-quality population-based cancer registries of four prefectures (Miyagi, Yamagata, Fukui and Nagasaki). Joinpoint regression analysis was performed to examine the trends in age-standardized rates of cancer incidence and mortality. Results: All-cancer mortality decreased from the mid-1990s, with an annual percent change of -1.3% (95% confidence interval: -1.4, -1.3), while all-cancer incidence continually increased from 1985, with an annual percent change of 0.7% (95% confidence interval: 0.6, 0.8). Major cancer sites, particularly the liver, colorectum and lung (males), showed a pattern of increasing incidence and mortality rates until the mid-1990s, stabilizing or decreasing thereafter. Stomach cancer showed a long-term decreasing trend for both incidence and mortality, while female breast cancer showed a continuously increasing trend. The incidence of prostate cancer, particularly at the localized stage, increased rapidly between 2000 and 2003, while that of mortality decreased from 2004. No changes were detected in the incidence or mortality for colorectal, female breast or cervical cancers after the establishment of national screening programs for these cancers. Conclusions: The analysis of cancer trends in Japan revealed a recent decrease in mortality and a continuous increase in incidence, which are considered to reflect changes in the underlying risk factors such as tobacco smoking and infection, and are partially explained by early detection and improved treatment.
Changing Trends in the Prevalence of H . Pylori Infection in Japan (1908–2003): a Systematic Review and Meta-Regression Analysis of 170,752 Individuals

Chaochen Wang,Takeshi Nishiyama,Shogo Kikuchi,Manami Inoue,Norie Sawada,Shoichiro Tsugane,Yingsong Lin

DOI: https://doi.org/10.1038/s41598-017-15490-7

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Changing trends in the prevalence of H. pylori infection in the general population over time are thought to be the main driving force behind the declining gastric cancer mortality in Japan. However, whether the prevalence of H. pylori infection itself shows a birth-cohort pattern needs to be corroborated. We performed a systematic review of studies that reported the prevalence of H. pylori infection among Japanese individuals. Meta-regression was conducted in the framework of a generalized additive mixed model (GAMM) to account for heterogeneity in the prevalence of H. pylori infection as a function of birth year. The prevalence of H. pylori infection confirmed a clear birth cohort pattern: the predicted prevalence (%, 95% CI) was 60.9 (56.3-65.4), 65.9 (63.9-67.9), 67.4 (66.0-68.7), 64.1 (63.1-65.1), 59.1 (58.2-60.0), 49.1 (49.0-49.2), 34.9 (34.0-35.8), 24.6 (23.5-25.8), 15.6 (14.0-17.3), and 6.6 (4.8-8.9) among those who were born in the year 1910, 1920, 1930, 1940, 1950, 1960, 1970, 1980, 1990, and 2000, respectively. The present study demonstrated a clear birth-cohort pattern of H. pylori infection in the Japanese population. The decreased prevalence of H. pylori infection in successive generations should be weighed in future gastric cancer control programs.
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021

Hidekatsu Nakai,Takahiro Higashi,Tamaki Kakuwa,Noriomi Matsumura

DOI: https://doi.org/10.1007/s10147-024-02473-8

2024-02-22

International Journal of Clinical Oncology

Abstract:In Japan, comprehensive cancer statistics data have been collected through national cancer registries, but these data are rarely summarized and reported in research articles.

oncology
Cancer Incidence and Mortality in Asian Countries: A Trend Analysis

Junjie Huang,Chun Ho Ngai,Yunyang Deng,Man Sing Tin,Veeleah Lok,Lin Zhang,Jinqiu Yuan,Wanghong Xu,Zhi-Jie Zheng,Martin C. S. Wong

DOI: https://doi.org/10.1177/10732748221095955

2022-06-30

Cancer Control

Abstract:Background This study aimed to evaluate the updated burden and temporal trends of cancer incidence and mortality in Asian countries. Methodology The data used in this study were retrieved from the Global Cancer Observatory, Cancer Incidence in Five Continents volumes I-XI, and the World Health Organization mortality database. These data were used to calculate the Average Annual Percentage Change (AAPC), with a 95% confidence interval (CI) by joinpoint regression analysis to determine the epidemiological trend in the past decade. Results In 2020, the cancer incidence in Asia was 169.1 per 1 00 000, accounting for 49.3% of the global cancer incidence. The most common cancers included lung (13.8%), breast (10.8%) and colorectal (10.6%) cancers. Its mortality was 101.6 per 1 00 000 (58.3% of the global cancer death) with lung (19.2%), liver (10.5%) and stomach (9.9%) cancers being the most common causes of cancer death. The cancer incidence had been increasing in female population, with Korea (AAPC = 5.73, 95% CI [5.30, 6.17], P < .001), Japan (AAPC = 2.67, 95% CI [2.12, 3.23], P < .001) and Kuwait (AAPC = 2.08, 95% CI [.49, 3.69], P = .016) showing the most significant increases in the past decade. The incidence increase was also observed among population aged <40 years old, with Korea (female AAPC = 8.42, 95% CI [7.40, 9.45], P < .001; male AAPC = 5.28, 95% CI [4.23, 6.33], P <.001), China (female AAPC = 2.94, 95% CI [2.07, 3.81], P < .001; male AAPC = 1.37, 95% CI [.57, 2.18], P = .004) and Japan (female AAPC = 2.88, 95% CI [1.88, 3.88], P = .016; male AAPC = 1.59, 95% CI [.40, 2.78], P = .015) showing the most significant increases. However, there was an overall decreasing trend of cancer mortality. Conclusions There was a substantial burden of cancer incidence and mortality in Asia. Although there was a decreasing trend in cancer mortality, its incidence had been increasing especially among female and younger populations. Future studies could be done to further investigate the potential reasons for these epidemiologic trends.

oncology
Occupation- and industry-specific cancer mortality among Japanese women from 1980 to 2015

Bibha Dhungel,Tomoe Murakami,Stuart Gilmour,Shunya Ikeda,Koji Wada

DOI: https://doi.org/10.1186/s12889-022-14304-4

IF: 4.5

2022-11-01

BMC Public Health

Abstract:Background: The number of women in Japan who continue working after childbirth is on the rise. Over the past few years, Japan's cancer mortality rate has increased. About 50% of all cancer deaths among Japanese women aged 25-64 are caused by lung, gastric, pancreatic and colorectal cancers. This study aims to examine the difference in mortality risk for key cancers among women and explore the effect of the economic crisis in the mid-1990s separately for occupational and industrial categories. Methods: Data from 1980 to 2015 were gathered from the Japanese Population Census and National Vital Statistics conducted in the same year. A Poisson regression analysis was used to estimate mortality risk and mortality trends for lung, gastric, pancreatic and colorectal cancer among Japanese working women aged 25-64 years. Results: Across most industrial and occupational groups, the trends in age-standardised cancer mortality rate for women have declined. Workers in management, security and transportation have a higher cancer mortality risk than sales workers. The risk of death from all four cancers is higher for workers in the mining and electricity industries than for wholesale and retail workers. Conclusion: To improve the health and well-being of employed Japanese women, it is crucial to monitor cancer mortality trends. Using these population-level quantitative risk estimates, industry- and occupation-specific prevention programmes can be developed to target women at higher cancer risk and enable the early detection and treatment of cancer.
Recent Increase in the Breast Cancer Incidence Among Japanese Women Seems to Correlate With the Prevalence of Drinking and Smoking Habits, but Not Obesity, as a Modern Lifestyle

Yuji Aoki,Amane Niitsu,Yui Nishizawa,Kazumi Baba,Rika Hatakeyama

DOI: https://doi.org/10.1093/cdn/nzac052.002

2022-06-01

Current Developments in Nutrition

Abstract:Objectives We have recently reported that age-specific incidence rates of breast cancer among Japanese women clearly increased from 2000 to 2015 in a bimodal distribution pattern with two peaks at the age groups of 45 to 49 and 60 to 64 years. The present study aimed to assess the association of age-specific breast cancer incidence rates with the prevalence of obesity and drinking and smoking habits among Japanese women, compared with those of uterine body, colon and lung cancers. Methods Age-specific cancer incidence and mortality rates and the prevalence of obesity and drinking and smoking habits were obtained from national data published by Cancer Information Services or National Institute of Health and Nutrition of Japan. Linear correlations of annual rates from 2005 to 2015 of the 10-year age-specific cancer incidence and mortality with the prevalence of obesity (body mass index, 25 and over) and drinking (alcohol, 20g and over 3 times or more a week) and smoking habits during the same 10-year period or the 10-year period 10 years before the cancer incidence and mortality were assessed by Pearson’s correlation coefficients. Results Significant (p < 0.05) and positive correlations were found between breast cancer incidence and drinking habits during the same period at the age of 50–59 (r = 0.901), 60–69 (r = 0.808) and 70–79 years (r = 0.643) and during the 10-year-before period at 50–59 (r = 0.676); between the incidence and smoking habits during the 10-year-before period at 40–49 (r = 0.897), 50–59 (r = 0.731) and 60–69 (r = 0.696); between the mortality and drinking habits during the same period at 30–39 (r = 0.739), 60–69 (r = 0.817) and 70–79 (r = 712); and between the mortality and smoking habits during the same period at 30–39 (r = 0.733) and during the 10-year-before period at 60–69 (r = 0.663). Similar but less positive correlations for uterine body cancer or more positive correlations for male lung cancer were found. The prevalence of male drinking and smoking habits was decreasing during the 20 years. No positive correlations were found between the breast cancer incidence or mortality and the prevalence of obesity. Conclusions The present ecological study demonstrated that the prevalence of drinking and smoking habits, but not obesity, as a modern lifestyle correlated with the recent increase in the age-specific breast cancer incidence among Japanese women. Funding Sources None.
Trends in cervical cancer incidence and mortality of young and middle adults in Japan

Sayo Tanaka,Matthew Palmer,Kota Katanoda

DOI: https://doi.org/10.1111/cas.15320

IF: 5.7

2022-03-15

Cancer Science

Abstract:Cancer Science, Accepted Article.

oncology
Incidence and Mortality Trends in Gastric Cancer in the United States, 1992-2019.

Mengding Chen,Ke Chen,Huanan Hou,Wanjing Li,Xiaoshan Wang,Qianze Dao,Zhengguang Wang

DOI: https://doi.org/10.1002/ijc.34415

2023-01-01

International Journal of Cancer

Abstract:Our study aimed to estimate the epidemiological trends of gastric cancer in the United States from 1992 to 2019. This population-based study used the US Surveillance, Epidemiology and End Results-12 database as a fundamental cohort to analyze gastric cancer incidence, incidence-based mortality (IBM), overall survival (OS) and cancer-specific survival (CSS) probabilities from 1992 to 2019. The Global Burden of Disease study (1990-2018) was used as a likely validation cohort. Age-period-cohort analyses were performed to explore the underlying causes of trend changes. We found that the incidence rate of gastric cancer decreased from 1992 to 2019. IBM also decreased significantly from 1997 to 2019. The 3-year OS and CSS of gastric cancer increased from 22.3% to 28.7% and 25.7% to 33.5%, respectively. However, the proportion of distant gastric cancer cases had unexpectedly increased rapidly from 33.1% in 1992 to 44.7% in 2019. Age-period-cohort modeling found that the incidence and IBM rates remained stable in the groups aged below 50 years, while that in all age groups older than 50 years showed a significant downward trend. High incidence and mortality risks were observed in the younger birth cohorts (birth year after 1990). To conclude, we observed a decline in incidence and mortality rates of gastric cancer in the United States in the past decades. We determined that progression of primary and tertiary preventive measures is the main reason for the reduction in the disease burden of gastric cancer. However, secondary preventive measures for gastric cancer still need to be strengthened.
A scalable and accurate algorithm for the computation of Hartree-Fock exchange

I. Duchemin,F. Gygi

DOI: https://doi.org/10.1016/j.cpc.2009.12.021

IF: 4.717

2010-05-01

Computer Physics Communications

Abstract:
Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan

Dongli Guo,Jing Jin,Daojuan Li,Yutong He,Yingsong Lin

DOI: https://doi.org/10.1002/ijc.35003

2024-05-23

International Journal of Cancer

Abstract:What's new? The incidence of esophageal cancer is disproportionately high in East Asia, where China alone has historically accounted for about half of the world's esophageal malignancies. In this study, the authors investigated recent trends in incidence and mortality for esophageal cancer specifically in China and Japan. Analyses show that incidence and mortality rates are declining in China, while mortality is declining in Japan. Most patients are diagnosed at stage III in China, versus stage I in Japan. The findings offer insight into esophageal cancer trends and patterns in China and Japan and could help identify areas for improvement in prevention. This study aims to analyze the prevalence trend of esophageal cancer in Japan and China to provide suggestions for the prevention and treatment of esophageal cancer. The results showed that the incidence rate for the years 2010–2018 significantly decreased with an APC of 5.66%, and the mortality rate from 2010 to 2015 had an APC of −5.87% in China. However, the incidence rate of Japanese women showed an upward trend, with an APC of 4.09% from 2010 to 2019. The mortality rate of esophageal cancer in Japan showed a downward trend, with an APC of −2.96% from 2010 to 2021. From 2010 to 2018, Chinese esophageal squamous cell carcinoma accounted for the highest proportion, accounting for 85.96%, with the largest distribution in the middle, accounting for 47.25%. Patients are mostly diagnosed at stage III, and the relative survival rate from 2012 to 2015 was 30.3%. Japan also has the highest proportion of squamous cell carcinoma, and the lesions are also mostly located in the middle segment. While Japanese esophageal cancer patients are mostly diagnosed at stage I, and the relative survival rate was 41.5% in Japan from 2009 to 2011. The results of this article indicate that the current prevalence of esophageal cancer in China and Japan is generally declining, and the quality of life of patients is gradually improving, but effective screening and prevention strategies are still needed to reduce the burden of this disease.

oncology
Global incidence and mortality of breast cancer: a trend analysis

Junjie Huang,Paul Sf Chan,Veeleah Lok,Xiao Chen,Hanyue Ding,Yinzi Jin,Jinqiu Yuan,Xiang-Qian Lao,Zhi-Jie Zheng,Martin Cs Wong,Paul SF Chan,Xiang-qian Lao,Martin CS Wong

DOI: https://doi.org/10.18632/aging.202502

2021-02-11

Aging

Abstract:This study aimed to evaluate the global incidence and mortality trends of breast cancer among females by region and age in the past decade. We retrieved country-specific incidence and mortality data from the Global Cancer Observatory up to 2018 and Cancer Incidence in Five Continents volumes I-XI, the Nordic Cancer Registries, the Surveillance, Epidemiology, and End Results, and WHO mortality database up to 2016. The temporal patterns were using Average Annual Percent Change (AAPC) with the 95% confidence interval (CI) by joinpoint regression analysis. Most countries showed an increasing trend in incidence. For the older population aged ≥ 50 years, Japan (5.63, 4.90-6.36), Slovakia (3.63, 3.03-4.22), China (2.86, 2.00-3.72) reported the most prominent increase. For young females (<50 years), Japan (AAPC=3.81, 95% CI=2.71-4.93), Germany (AAPC=2.60, 95% CI=1.41-3.81) and Slovakia (1.91, 1.13-2.69) reported the most drastic rise. Similarly, 12 countries showed an incidence increase among women aged <40 years. As for mortality, the Philippines (4.36, 3.65-5.07), Thailand (4.35, 3.12-5.59), Colombia (0.75, 0.08-1.42), and Brazil (0.44, 0.19-0.68) reported a significant increase. The disease burden of breast cancer showed an increasing trend in a large number of populations. More preventive efforts are recommended for these countries. Further research should explore the underlying reasons for these epidemiological trends.

English Else
Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study

Akira Sato,Keisuke Matsubayashi,Toshitaka Morishima,Kayo Nakata,Koji Kawakami,Isao Miyashiro

DOI: https://doi.org/10.1186/s12885-021-08011-3

IF: 4.638

2021-03-10

BMC Cancer

Abstract:Abstract Background Cancer survivors are frequently excluded from clinical research, resulting in their omission from the development of many cancer treatment strategies. Quantifying the prevalence of prior cancer in newly diagnosed cancer patients can inform research and clinical practice. This study aimed to describe the prevalence, characteristics, and trends of prior cancer in newly diagnosed cancer patients in Japan. Methods Using Osaka Cancer Registry data, we examined the prevalence, characteristics, and temporal trends of prior cancer in patients who received new diagnoses of lung, stomach, colorectal, female breast, cervical, and corpus uterine cancer between 2004 and 2015. Site-specific prior cancers were examined for a maximum of 15 years before the new cancer was diagnosed. Temporal trends were evaluated using the Cochran-Armitage trend test. Results Among 275,720 newly diagnosed cancer patients, 21,784 (7.9%) had prior cancer. The prevalence of prior cancer ranged from 3.3% (breast cancer) to 11.1% (lung cancer). In both sexes, the age-adjusted prevalence of prior cancer had increased in recent years ( P values for trend < 0.001), especially in newly diagnosed lung cancer patients. The proportion of smoking-related prior cancers exceeded 50% in patients with newly diagnosed lung, stomach, colorectal, breast, and cervical cancer. Conclusions The prevalence of prior cancer in newly diagnosed cancer patients is relatively high, and has increased in recent years. Our findings suggest that a deeper understanding of the prevalence and characteristics of prior cancer in cancer patients is needed to promote more inclusive clinical research and support the expansion of treatment options.

oncology
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry

Takayuki Iwamoto,Hiraku Kumamaru,Naoki Niikura,Yasuaki Sagara,Minoru Miyashita,Takaaki Konishi,Naoko Sanuki,Kenta Tanakura,Masayuki Nagahashi,Naoki Hayashi,Masayuki Yoshida,Chie Watanabe,Naoko Kinukawa,Masakazu Toi,Shigehira Saji

DOI: https://doi.org/10.1007/s12282-024-01545-x

2024-02-08

Breast Cancer

Abstract:This is a prognostic report by the Japanese Breast Cancer Society on breast cancer extracted from the National Clinical Database-Breast Cancer Registry of Japan. Here, we present a summary of 457,878 breast cancer cases registered between 2004 and 2016. The median follow-up duration was 5.6 years. The median age at the start of treatment was 59 years (5–95%: 38–82 years) and increased from 57 years between 2004 and 2008 to 60 years between 2013 and 2016. The proportion of patients with Stage 0–II disease increased from 74.5% to 78.3%. The number of cases with estrogen and progesterone receptor positivity increased from 74.8% to 77.9% and 60.5% to 68.1%, respectively. Regarding (neo-)adjuvant chemotherapy, the taxane (T) or taxane-cyclophosphamide (C) regimen increased by 2.4% to 8.2%, but the (fluorouracil (F)) adriamycin (A)-C-T/(F) epirubicin (E)C-T and (F)AC/(F)EC regimens decreased by 18.6% to 15.2% and 13.5% to 5.0%, respectively. Regarding (neo-)adjuvant anti-human epidermal growth factor-2 (HER2)-targeted therapy, the use of trastuzumab increased from 4.6% to 10.5%. The rate of sentinel lymph node biopsy increased from 37.1% to 60.7%, while that of axillary dissection decreased from 54.5% to 22.6%. Improvements in disease-free and overall survival were observed in patients with HER2-positive breast cancer, but there was no apparent trend in patients with hormone receptor-positive, HER2-negative, or triple-negative breast cancers.

oncology,obstetrics & gynecology
Trends in endometrial carcinoma: experience of a single institute for four decades

Masayuki Yamaguchi,Naohisa Kushiya,Ryo Tamura,Nobumichi Nishikawa,Akira Kikuchi

DOI: https://doi.org/10.1093/jjco/hyae012

IF: 2.925

2024-02-09

Japanese Journal of Clinical Oncology

Abstract:Abstract Objective To determine the current prognosis of endometrial carcinoma in Japan by analyzing long-term trends in endometrial carcinoma at our hospital. Methods We divided 1463 patients with endometrial carcinoma who visited our hospital between 1984 and 2022 into group 1984–1991, group 1992–1999, group 2000–2006, group 2007–2014 and group 2015–2022. Trends were determined using the Jonckheere–Terpstra and Cochran–Armitage tests. Data were analyzed using Cox regression analysis. Results When group 2015–2022 was used as a reference in the univariate analysis, the hazard ratios for the other groups were <1. In particular, the hazard ratio for group 2007–2014 was 0.65 (95% confidence interval, 0.47–0.90, P = 0.009), suggesting that the prognosis of group 2015–2022 was worse than that of group 2007–2014 and seemed to be the worst among all prognoses. In multivariate analysis, the hazard ratios for each group were 1.38, 1.42, 1.88, 1.16 and 1, respectively; the group with the worst prognosis changed from group 2015–2022 to group 2000–2006 (hazard ratio, 1.88; 95% confidence interval, 1.27–2.78, P = 0.001). Age and the rate of non-endometrioid carcinoma exhibited significantly increasing trends (P < 0.001 and P < 0.001, respectively), as did the rates of serous and mixed carcinomas (P = 0.001 and 0.024, respectively). The rates of non-endometrioid carcinoma, serous carcinoma and mixed carcinoma were 19.0%, 5.5% and 3.1% in group 2007–2014 and 28.2%, 10.8% and 4.6% in group 2015–2022, respectively. Conclusions The increasing rates of non-endometrioid carcinoma—especially serous and mixed carcinoma—may be associated with the worsening prognosis of endometrial carcinoma at our institution. Careful monitoring is needed to confirm whether this phenomenon is observed throughout Japan.

oncology
Trends and future projections of cervical cancer-related outcomes in Japan: What happens if the HPV vaccine program is not implemented?

Atsuko Sakakibara,Takeo Nakayama,Hiroyuki Uchida,Youichi Odagiri,Yuri Ito,Toshiro Katayama,Yutaka Ueda,Toshihiro Higuchi,Koichi Terakawa,Kunihiko Matsui,Kikuko Miyazaki,Ikuo Konishi

DOI: https://doi.org/10.1002/ijc.34391

2023-05-01

Abstract:Contrary to other developed countries, in Japan, recent years have seen increases in cervical cancer incidence and mortality among young people. However, the human papillomavirus (HPV) vaccine program, a key measure for avoiding cervical cancer, has been virtually suspended. Temporal changes in cervical cancer profiles in this unique situation have not been fully investigated epidemiologically. Our study aimed to determine the current status and future trends of the incidence and mortality of cervical cancer and precancerous lesions in Japan. Mortality rates of cervical cancer during 1975 to 2016 and incidence rates of cervical cancer and cervical intraepithelial neoplasia (CIN) 3 during 1975 to 2013 were examined using vital statistics and population-based cancer registry data in Japan. Bayesian age-period-cohort analyses were performed to analyze temporal changes of the three cervical cancer-related outcomes. We also calculated projections to 2028 for the three outcomes, assuming that HPV vaccination coverage and screening rates in Japan would be maintained at the current level after the resumption of the national vaccination program. The risk of occurrence of the three outcomes showed similar changes by birth cohort, peaking in the mid-1890s to 1900s birth cohorts, declining sharply in the 1940s birth cohort, and persistently increasing in the 1950s and later birth cohorts. Projections to 2028 show increases in cervical cancer incidence and mortality in the 30 to 69 age group, with a particular increase in CIN3 incidence in the 25 to 49 age group, if HPV vaccine programs and screening are not effectively implemented. These findings revealed an increasing cervical disease burden among reproductive age females in Japan.
Trends in non‐Hodgkin lymphoma mortality rate in Japan and the United States: A population‐based study

Yoshiaki Usui,Hidemi Ito,Kota Katanoda,Tomohiro Matsuda,Yoshinobu Maeda,Keitaro Matsuo

DOI: https://doi.org/10.1111/cas.15926

IF: 5.7

2023-08-20

Cancer Science

Abstract:The arrival of the first molecular targeted agent, rituximab, for non‐Hodgkin lymphoma (NHL) led to a paradigm shift in NHL treatment. Here, we evaluated mortality and incidence rates of NHL in Japan and the United States to understand the public health impact of novel treatments. Despite an increase in incidence, the mortality rates in all age groups weakened the upward trends or decreased in both countries after the introduction of rituximab. Characterizing trends in mortality rates with consideration of trends in incidence rates at the population level could help identify unmet needs in public health and provide essential indicators of cancer control. In the late 20th century, the arrival of the first molecular targeted agent, rituximab, for non‐Hodgkin lymphoma (NHL) led to a paradigm shift in NHL treatment. However, the public health impact of this arrival has not been fully clarified. Here, we evaluated trends in the mortality and incidence rates of NHL in Japan and the United States. Age‐standardized rates of mortality reversed after the introduction of rituximab, around 2000, beginning to decline significantly with annual percent changes (95% confidence interval) of −2.6% (−3.6% to −1.6%) in Japan and − 3.9% (−4.2% to −3.5%) in the United States. Despite an increase in incidence, the mortality in all age groups weakened the upward trends or decreased in both countries. From a long‐term perspective, the trends in mortality rates differed between the countries. In the United States, the mortality rate has declined continuously since the introduction of rituximab, with a declining incidence rate. In contrast, in Japan, the mortality rate stopped declining and the incidence rate increased remarkably. The introduction of rituximab has had a substantial impact at the population level across a wide range of individuals. To reduce the disease burden in terms of mortality, elucidating risk factors that lead to a decreasing incidence rate is warranted for NHL, as well as further development of novel treatments.

oncology
Incidence, mortality, survival, and treatment statistics of cancers in digestive organs—Japanese cancer statistics 2024

Takahiro Higashi,Yukinori Kurokawa

DOI: https://doi.org/10.1002/ags3.12835

2024-06-19

Annals of Gastroenterological Surgery

Abstract:Statistical information is essential for clinical cancer research and policymaking processes. The essential information was summarized in this paper to help users of these statistics understand how these are made and what caution they need to take when interpreting the numbers. Access to accurate statistical data is paramount in the pursuit of effective cancer control activities, including research, policy development, and clinical care. This paper presents a comprehensive statistical report on the incidence, mortality, survival, and treatment of major digestive organ cancers, including those of the esophagus, stomach, colon, rectum, liver, extrahepatic biliary tract, and pancreas, in Japan. We compiled data from the National Cancer Center's "Cancer Information Services" and government "e‐Stat" websites and offered a succinct overview of basic statistics by using tables and graphical presentations. Our findings underscore the critical role of the National Cancer Registry introduced by the Cancer Registry Act of 2016, which mandates hospitals across Japan to report cancer cases. This system ensures more accurate incidence statistics. Mortality data sourced from the National Vital Statistics System and survival rates derived from hospital‐based cancer registries offer insights into the outcomes and efficacy of treatment modalities. These data indicate a downward trend in mortality for stomach and liver cancers and stable or declining rates for other cancers except pancreatic cancer, which has the lowest survival rate. Treatment patterns indicate an increase in endoscopic procedures for esophageal and stomach cancers, with stable treatment approaches for colorectal cancer. This statistical overview aims to improve the understanding and inform research, policy, and clinical decisions in the field of digestive organ cancers.

gastroenterology & hepatology
Gastric Cancer Incidence Trends in China and Japan from 1990 to 2019: Disentangling Age–period–cohort Patterns

Yuansheng Li,Ningjun Ren,Beibei Zhang,Chao Yang,Ailing Li,Xiang Li,Zhi Lei,Liping Fei,Song Fan,Junhui Zhang

DOI: https://doi.org/10.1002/cncr.34511

IF: 6.9209

2022-01-01

Cancer

Abstract:Background Recent data have shown divergent trends in gastric cancer (GC) incidence between China and Japan; however, the cause for has not been explored. Methods We retrieved GC incidence data from 1990 to 2019 from the Global Burden of Disease study, stratified by sex for both countries. We analyzed annual average percentage change (AAPC) via a joinpoint regression model and estimated the effects of age, period, and cohort via the age-period-cohort model. Results The age-standardized incidence rate trends for GC decreased in both countries and both sexes, but the reduction was more pronounced in Japan because the AAPC for Japanese males (AAPC = -2.65%; 95% CI, -2.98 to -2.32) was eight times greater than that of Chinese males (AAPC = -0.30%; 95% CI, -0.5 to -0.09). The age and cohort effects on the trend are similar in both countries: the risk of GC incidence increased with age among the Chinese and the Japanese but was lower among younger birth cohorts. The two countries showed contrasting trends over the study period; although the risk of GC rapidly decreased for Japanese males and females, it increased by twofold among Chinese males. Conclusions The period effect is the main reason for the divergent trends in age-standardized incidence rate for GC in China and Japan. By comparing national cancer control programs in both countries, we concluded that countries with a high prevalence of GC, such as China, can learn from Japan's experience in controlling GC by actively conducting national population screening, which is expected to facilitate both prevention and treatment of GC. Lay summary More than one-half of all new gastric cancer (GC) worldwide occur in China and Japan, but the reasons for the different incidence trends have not been thoroughly analyzed. Analysis using the age-period-cohort model confirmed that the cohort effect was the main reason for the decline in age-standardized incidence rate (ASIR) for GC and that the period effect may be the main reason for the divergent trends in gastric cancer ASIR in China and Japan.
Temporal changes in cumulative mortality risks of cancer, by occupation, in the working population of Japan from 1995 to 2020: A benchmark for radiation risk comparison

Momo Takada,Jun Hirouchi,Ikuo Kujiraoka,Shogo Takahara,Thierry Schneider,Michiaki Kai

DOI: https://doi.org/10.1088/1361-6498/ad2ebc

2024-03-02

Journal of Radiological Protection

Abstract:The purpose of this study was to provide benchmark data for discussing the tolerability of cancer risk associated with occupational radiation exposure. It focused on differences in cancer mortality risk by occupation among Japan's working population and examined baseline cancer mortality risks and its variations from 1995 through 2020. Data were collected every five years from national vital statistics sources. By focusing on the same types of cancer among radiation induced effects, cumulative mortality risks were calculated for colorectal, lung, and breast cancer (females only) for those aged 15–74. The average cumulative mortality risk for the working population in Japan has decreased by 30–60% over the past 25 years. Service workers and male managers were at an average risk, among all workers, while clerical workers and transportation and manufacturing workers had about half the average risk. The risks were higher for professionals and female managers, about 1.5 to 2 times the average for professionals and up to 5 times the average for female managers. The decrease in the average cancer mortality risk in the working population as a baseline suggests that risk tolerance in society might have changed over time. Since differences in mortality by occupation were confirmed, the usefulness of occupational data as a benchmark needs further investigation, as high-risk/low-risk occupations vary by country and region. The results of this study contribute to put radiation risks into perspective with the background risk of cancer.

environmental sciences,public, environmental & occupational health,radiology, nuclear medicine & medical imaging,nuclear science & technology
Patterns of cancer treatment in different age groups in Japan: an analysis of hospital-based cancer registry data, 2012–2015

Ayako Okuyama,Takahiro Higashi

DOI: https://doi.org/10.1093/jjco/hyy032

IF: 2.925

2018-03-26

Japanese Journal of Clinical Oncology

Abstract:BACKGROUND: Because of the physiological decline and the diversity of preferences, treating older patients with cancer is challenging. Given the insufficient evidence applicable to treating cancer in older patients, some clinical guidance is necessary. This study provides a description of current treatment practices in Japan, which may shed light on possible treatment options.METHODS: Using data from the national database of hospital-based cancer registries, we described the first-course treatment of nine common cancers in patients who received care in Designated Cancer Care Hospitals between 2012 and 2015. We compared the patterns of first-course cancer treatment between younger and older patients.RESULTS: In total, 1 383 066 cases were analysed. The proportion of patients aged >75 years receiving first-course treatment has gradually increased since 2012 (range: 0.9% point increase for colorectal cancer to 2.7% point increase for stomach cancer). A higher proportion of patients aged ≥85 years, compared with younger patients, did not receive any treatment.CONCLUSIONS: Based on this cancer registry-based analysis, older patients-in particular those ≥85 years old at diagnosis and with advanced stage cancer-are less likely to receive anti-cancer treatment than younger patents are. Further research is warranted to identify patient characteristics that predict which older patients are most likely to benefit from active treatment.

oncology

[Antitumor activity of shi-quan-da-bu-tang and its effects on interferon-gamma and interleukin 2 production].

An updated report of the trends in cancer incidence and mortality in Japan

Changing Trends in the Prevalence of H . Pylori Infection in Japan (1908–2003): a Systematic Review and Meta-Regression Analysis of 170,752 Individuals

Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021

Cancer Incidence and Mortality in Asian Countries: A Trend Analysis

Occupation- and industry-specific cancer mortality among Japanese women from 1980 to 2015

Recent Increase in the Breast Cancer Incidence Among Japanese Women Seems to Correlate With the Prevalence of Drinking and Smoking Habits, but Not Obesity, as a Modern Lifestyle

Trends in cervical cancer incidence and mortality of young and middle adults in Japan

Incidence and Mortality Trends in Gastric Cancer in the United States, 1992-2019.

A scalable and accurate algorithm for the computation of Hartree-Fock exchange

Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan

Global incidence and mortality of breast cancer: a trend analysis

Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study

Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry

Trends in endometrial carcinoma: experience of a single institute for four decades

Trends and future projections of cervical cancer-related outcomes in Japan: What happens if the HPV vaccine program is not implemented?

Trends in non‐Hodgkin lymphoma mortality rate in Japan and the United States: A population‐based study

Incidence, mortality, survival, and treatment statistics of cancers in digestive organs—Japanese cancer statistics 2024

Gastric Cancer Incidence Trends in China and Japan from 1990 to 2019: Disentangling Age–period–cohort Patterns

Temporal changes in cumulative mortality risks of cancer, by occupation, in the working population of Japan from 1995 to 2020: A benchmark for radiation risk comparison

Patterns of cancer treatment in different age groups in Japan: an analysis of hospital-based cancer registry data, 2012–2015